Axsome Therapeutics Inc (AXSM)

[smallbio]

The link below has some numbers on depression & antidepressant cost.

http://time.com/4900248/antidepressants-depression-more-common/

"As TIME reported in a recent cover story, clinical depression affects about 16 million people in the U.S. and is estimated to cost the U.S. about $210 billion a year in productivity loss and health care needs. Global revenue for antidepressants is projected to grow to nearly $17 billion by 2020."

IF AXS-05 is as effective as ASCEND trial plus prove to be safe long term, it should take a % out of 17B projected annual US market.

The company had 1% estimate a while back for TRD (before MDD ASCEND readout).